{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:25:12Z","timestamp":1759530312512},"reference-count":16,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Chemical Toxicology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.3109\/01480545.2011.641020","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T10:19:01Z","timestamp":1323944341000},"page":"445-449","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of mutagenic effect of two antiobesity drugs on mice\u2019s genetic materials"],"prefix":"10.3109","volume":"35","author":[{"given":"Sahar","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inas","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1002\/msj.20207"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-7661-7_2"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1177\/0960327109358732"},{"key":"CIT0005","author":"Delaet D.","year":"2011","journal-title":"Clin Evid (Online)"},{"key":"CIT0006","author":"Halpern A.","year":"2010","journal-title":"J Obes Epub"},{"key":"CIT0007","unstructured":"Harmonized Tripartite Guideline S2(R1). (2008). Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (pp. 1\u201326). Geneva: ICH."},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1110(83)90047-7"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(00)00117-2"},{"key":"CIT0010","volume-title":"Human genetics: concepts and applications","author":"Lewis R","year":"2005","edition":"6"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/14740330903321485","volume":"8","author":"McClendon K. S.","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03453.x"},{"key":"CIT0013","volume-title":"Evaluation of drug activities in Pharmacoments","author":"Paget G. E.","year":"1964","edition":"1"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-010-0080-y"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1218(87)90021-8"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(80)90193-4"},{"key":"CIT0017","first-page":"44","volume":"82","author":"Vlasova I.","year":"2010","journal-title":"Ter Arkh"}],"container-title":["Drug and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/01480545.2011.641020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T11:23:21Z","timestamp":1497957801000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3109\/01480545.2011.641020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,11,15]]},"published-print":{"date-parts":[[2012,10]]}},"alternative-id":["10.3109\/01480545.2011.641020"],"URL":"https:\/\/doi.org\/10.3109\/01480545.2011.641020","relation":{},"ISSN":["0148-0545","1525-6014"],"issn-type":[{"value":"0148-0545","type":"print"},{"value":"1525-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}